Guselkumab Significantly Improves Disease Activity in PsA Over 100 Weeks

Continuous improvement across all MDA domains was demonstrated over the 100-week timeframe, with approximately 70% of patients achieving near remission in swollen joint count, enthesitis, and the Psoriasis Area and Severity Index (PASI).

Related Keywords

Nuffield ,Oxfordshire ,United Kingdom ,Laurac Coates ,Nuffield Department Of Orthopedics ,University Of Oxford ,Health Assessment Questionnaire ,Group For Research ,University Of Oxford Laurac Coates ,Musculoskeletal Sciences ,Nuffield Department ,Psoriasis Area ,Severity Index ,Health Assessment Questionnaire Disability Index ,Psoriatic Arthritis ,